Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in MRK — Merck & Co., Inc.

CIK 70858 CHARLOTTE, NC
Back to MRK Full portfolio

Position in MRK

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$3,701,831,041
+$769,872,585 QoQ
Shares Held
30,774,221
+10.5% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 48.01937959696851.ToString("F0")% Shared 0.ToString("F0")% None 51.98062040303149.ToString("F0")%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Sep 30, 2025
CallValue
$138,828,613
CallShares
1,654,100
PutValue
$155,362,823
PutShares
1,851,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. MRK ranks #5 (9.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 11,125,832 $10,233,206,495
2 JNJ
Johnson & Johnson
 25,516,697 $6,237,301,411
3 ABBV
AbbVie Inc.
 23,936,943 $5,206,045,728
4 AZN
Astrazeneca PLC
 19,058,327 $3,758,683,247
5 MRK
Merck & Co., Inc.
This page 		30,774,221 $3,701,831,041
6 GILD
Gilead Sciences, Inc.
 19,978,936 $2,784,464,307
7 BMY
Bristol Myers Squibb Co
 32,586,981 $1,976,400,394
8 AMGN
Amgen Inc
 5,121,028 $1,801,833,698

All Filings in MRK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,701,831,041 30,774,221
2025-12-31 $2,931,958,456 27,854,441
2025-09-30 $138,828,613 1,654,100
2025-09-30 $155,362,823 1,851,100
2025-09-30 $2,219,901,160 26,449,436
2025-06-30 $165,840,200 2,095,000
2025-06-30 $2,218,152,964 28,021,134
2025-06-30 $205,364,788 2,594,300
2025-03-31 $148,032,192 1,649,200
2025-03-31 $211,528,416 2,356,600
2025-03-31 $2,790,121,826 31,084,245
2024-12-31 $94,734,804 952,300
2024-12-31 $3,625,542,826 36,444,942
2024-12-31 $126,001,368 1,266,600
2024-09-30 $143,096,956 1,260,100
2024-09-30 $77,902,160 686,000
2024-09-30 $4,413,852,802 38,868,024
2024-06-30 $4,862,873,406 39,280,076
2024-06-30 $148,040,040 1,195,800
2024-06-30 $175,696,960 1,419,200
2024-03-31 $195,061,685 1,478,300
2024-03-31 $136,132,815 1,031,700
2024-03-31 $4,751,777,327 36,011,954
2023-12-31 $4,142,169,217 37,994,581
2023-12-31 $116,891,244 1,072,200
2023-12-31 $164,467,572 1,508,600
2023-09-30 $97,895,155 950,900
2023-09-30 $137,654,445 1,337,100
2023-09-30 $3,680,475,468 35,750,126
2023-06-30 $4,307,723,321 37,331,860
2023-06-30 $143,856,713 1,246,700
2023-06-30 $165,284,636 1,432,400
2023-03-31 $4,255,843,097 40,002,285
2023-03-31 $133,732,230 1,257,000
2023-03-31 $136,583,482 1,283,800
2022-12-31 $4,460,214,073 40,200,217
2022-12-31 $168,333,340 1,517,200
2022-12-31 $134,027,600 1,208,000
2022-09-30 $135,647,612 1,575,100
2022-09-30 $126,467,220 1,468,500
2022-09-30 $3,445,448,395 40,007,529
2022-06-30 $153,329,706 1,681,800
2022-06-30 $3,545,965,975 38,894,000
2022-06-30 $152,554,761 1,673,300
2022-03-31 $58,764,210 716,200
2022-03-31 $26,723,685 325,700
2022-03-31 $2,989,437,099 36,434,334
2021-12-31 $134,112,336 1,749,900
2021-12-31 $2,714,796,951 35,422,716
2021-12-31 $40,373,952 526,800

Report a Problem

Category
Description
Email (optional, for follow-up)